In this episode, we speak to Dr. Hans Sollinger, MD, PhD, Founder & Interim CSO of Endsulin. Dr. Sollinger has been a leader in diabetes care for decades and has revolutionized the field twice.
Endsulin is overcoming the limitations of today's taxing diabetes treatments with a patented gene construct and simple process that re-engineers part of the liver, allowing it to produce and regulate insulin on its own.
Podden och tillhörande omslagsbild på den här sidan tillhör the(sugar)science. Innehållet i podden är skapat av the(sugar)science och inte av, eller tillsammans med, Poddtoppen.
